ribociclib
novartis
['bcsm', 'natalee', 'breast', 'ribociclib']
ribociclib plus endocrine therapy showed a clinically and statistically significant improvement in idfs in patients with hr+ or her2 early breast cancer vs endocrine alone, according to findings from the phase 3 natalee trial. #bcsm #asco23 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.